CAS 54340-62-4|Bufuralol
| Common Name | Bufuralol | ||
|---|---|---|---|
| CAS Number | 54340-62-4 | Molecular Weight | 261.35900 |
| Density | 1.066g/cm3 | Boiling Point | 393.2ºC at 760 mmHg |
| Molecular Formula | C16H23NO2 | Melting Point | / |
| MSDS | / | Flash Point | 191.6ºC |
Names
| Name | (+/-)-bufuralol |
|---|---|
| Synonym | More Synonyms |
Bufuralol BiologicalActivity
| Description | Bufuralol (Ro 3-4787) is a potent non-selective, orally active β-adrenoreceptor antagonist with partial agonist activity. Bufuralol hydrochloride is a CYP2D6 probe substrate[1][2][3][4]. |
|---|---|
| Related Catalog | Research Areas >>Cardiovascular DiseaseResearch Areas >>EndocrinologySignaling Pathways >>GPCR/G Protein >>Adrenergic Receptor |
| Target | β-adrenoceptor |
| In Vitro | Bufuralol (Ro 3-4787) 广泛用于表征 CYP2D6 活性,并具有 CYP2D6 底物特有的芳香环和碱性氮[3]。 |
| In Vivo | Bufuralol (Ro 3-4787) 代谢由 NADPH 介导表现出双相动力学,其效率低于在和猴子肠道中观察到的氢过氧化异丙苯 (CuOOH) 存在的情况,这与在肝脏中的观察结果一致[4]。 |
| References | [1]. T H Pringle, et al. Pharmacodynamic and pharmacokinetic studies on bufuralol in man. Br J Clin Pharmacol. 1986 Nov;22(5):527-34. [2]. Jie Cai, et al. Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro. Basic Clin Pharmacol Toxicol. 2016 Mar;118(3):190-9. [3]. Sarah M Glass, et al. CYP2D6 Allelic Variants *34, *17-2, *17-3, and *53 and a Thr309Ala Mutant Display Altered Kinetics and NADPH Coupling in Metabolism of Bufuralol and Dextromethorphan and Altered Susceptibility to Inactivation by SCH 66712. Drug Metab Dispos. 2018 Aug;46(8):1106-1117. [4]. T Prueksaritanont, et al. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver. Biochem Pharmacol. 1995 Oct 26;50(9):1521-5. |
Chemical & Physical Properties
| Density | 1.066g/cm3 |
|---|---|
| Boiling Point | 393.2ºC at 760 mmHg |
| Molecular Formula | C16H23NO2 |
| Molecular Weight | 261.35900 |
| Flash Point | 191.6ºC |
| Exact Mass | 261.17300 |
| PSA | 45.40000 |
| LogP | 3.80760 |
| Index of Refraction | 1.558 |
| InChIKey | SSEBTPPFLLCUMN-UHFFFAOYSA-N |
| SMILES | CCc1cccc2cc(C(O)CNC(C)(C)C)oc12 |
Synonyms
| bryostatin1,0 |
| (26R)-Bryostatin 1 |
| [3H]-Bryostatin 1 |
| (1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-(Acetyloxy)-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-Methoxy-2-oxoethylidene)-10,10,26,26-tetraMethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-y |
| (1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-(Acetyloxy)-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl2,4-octadienoicacidester |
| BRYO 1 |
| BRYOSTATIN |
| bryostatine-1 |
| [3H]-Bufuralol |
| BRYOSTATIN 1 |
| 2,4-Octadienoic acid,(1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-(acetyloxy)-1,11,21-trihydroxy-17-(1R)-1-hydroxyethyl-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo21.3.1.13,7.111,15nonacos-8-en |
